These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3394817)

  • 61. Effect of Carnitine Supplementation in Pediatric Patients with Left Ventricular Dysfunction.
    Ikeda N; Loomba RS; Patel R; Dorsey V; Yousaf F; Nelson-McMillan K
    Pediatr Cardiol; 2023 Mar; 44(3):720-726. PubMed ID: 36107209
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Potential Effect of L-Carnitine on the Prevention of Myocardial Injury after Coronary Artery Bypass Graft Surgery.
    Dastan F; Hajhossein Talasaz A; Mojtahedzadeh M; Karimi A; Salehiomran A; Bina P; Jalali A; Aghaie Z
    J Tehran Heart Cent; 2015 Apr; 10(2):74-9. PubMed ID: 26110005
    [TBL] [Abstract][Full Text] [Related]  

  • 63. L-carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions.
    Löster H; Böhm U
    Mol Cell Biochem; 2001 Jan; 217(1-2):83-90. PubMed ID: 11269669
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat.
    Broderick TL; Driedzic W; Paulson DJ
    Mol Cell Biochem; 2000 Mar; 206(1-2):151-7. PubMed ID: 10839205
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of L-carnitine and its acetyl and propionyl esters on ATP and PCr levels of isolated rat hearts perfused without fatty acids and investigated by means of 31P-NMR spectroscopy.
    Löster H; Keller T; Grommisch J; Gründer W
    Mol Cell Biochem; 1999 Oct; 200(1-2):93-102. PubMed ID: 10569188
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention.
    Spagnoli LG; Mauriello A; Orlandi A; Sangiorgi G; Bonanno E
    Drugs Aging; 1996 Apr; 8(4):275-98. PubMed ID: 8920175
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acylcarnitines in intermediary metabolism.
    Sewell AC; Böhles HJ
    Eur J Pediatr; 1995 Nov; 154(11):871-7. PubMed ID: 8582396
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessment of the cardiostimulant action of propionyl-L-carnitine on chronically volume-overloaded rat hearts.
    el Alaoui-Talibi Z; Bouhaddioni N; Moravec J
    Cardiovasc Drugs Ther; 1993 Jun; 7(3):357-63. PubMed ID: 8364005
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of propionyl-L-carnitine in a rat model of peripheral arteriopathy: a functional, histologic, and NMR spectroscopic study.
    Corsico N; Nardone A; Lucreziotti MR; Spagnoli LG; Pesce D; Aureli T; Di Cocco ME; Miccheli A; Conti F; Arrigoni Martelli E
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):241-51. PubMed ID: 8357778
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir.
    Lopaschuk GD; McNeil GF; McVeigh JJ
    Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):175-9. PubMed ID: 2779537
    [TBL] [Abstract][Full Text] [Related]  

  • 71. L-propionyl-carnitine protection of mitochondria in ischemic rat hearts.
    Di Lisa F; Menabò R; Siliprandi N
    Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):169-73. PubMed ID: 2779536
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alterations in fatty acid oxidation in ischemic and reperfused myocardium.
    Huang XQ; Liedtke AJ
    Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):145-53. PubMed ID: 2674664
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Myocardial fatty acid homeostasis.
    van der Vusse GJ; Glatz JF; Stam HC
    Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):1-6. PubMed ID: 2674661
    [No Abstract]   [Full Text] [Related]  

  • 74. Biochemical profile of propionyl-L-carnitine.
    Hülsmann WC
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():7-9. PubMed ID: 2031874
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium.
    Yamada KA; Dobmeyer DJ; Kanter EM; Priori SG; Corr PB
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():67-76. PubMed ID: 2031873
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria.
    Ferrari R; Ceconi C; Cargnoni A; Pasini E; Boffa GM; Curello S; Visioli O
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():57-65. PubMed ID: 2031872
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart.
    Ferrari R; Pasini E; Condorelli E; Boraso A; Lisciani R; Marzo A; Visiou O
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():17-23. PubMed ID: 2031870
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism.
    Siliprandi N; Di Lisa F; Menabò R
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():11-5. PubMed ID: 2031869
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hemodynamic study of intravenous propionyl-L-carnitine in patients with ischemic heart disease and normal left ventricular function.
    Chiddo A; Gaglione A; Musci S; Troito G; Grimaldi N; Locuratolo N; Rizzon P
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():107-11. PubMed ID: 2031868
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.